{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T02:51:43Z","timestamp":1782960703662,"version":"3.54.5"},"reference-count":21,"publisher":"Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,10]]},"DOI":"10.31744\/einstein_journal\/2023ao0375","type":"journal-article","created":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T18:39:17Z","timestamp":1699900757000},"source":"Crossref","is-referenced-by-count":2,"title":["Anti-ribosomal P (anti-P) antibodies in patients with autoimmune hepatitis"],"prefix":"10.31744","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-4247-6471","authenticated-orcid":false,"given":"Clarisse de Almeida","family":"Gallo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8789-3785","authenticated-orcid":false,"given":"Alessandra","family":"Dellavance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4919-8420","authenticated-orcid":false,"given":"Raimundo Ara\u00fajo","family":"Gama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5579-5416","authenticated-orcid":false,"given":"Ant\u00f4nio Eduardo","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2189-562X","authenticated-orcid":false,"given":"Ivonete Sandra de Souza e","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8742-9931","authenticated-orcid":false,"given":"Luis Eduardo Coelho","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8992-8494","authenticated-orcid":false,"given":"Maria L\u00facia Gomez","family":"Ferraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16942","reference":[{"key":"key20231113133913_B1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaut.2013.08.001","article-title":"Clinical significance of autoantibodies in autoimmune hepatitis","volume":"46","author":"Liberal","year":"2013","unstructured":"1. Liberal R, Mieli-Vergani G, Vergani D. Clinical significance of autoantibodies in autoimmune hepatitis. J Autoimmun. 2013;46:17-24. Review.","journal-title":"J Autoimmun"},{"issue":"10","key":"key20231113133913_B2","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.3109\/00365521.2014.946083","article-title":"Epidemiology and clinical characteristics of autoimmune hepatitis in the Netherlands","volume":"49","author":"van Gerven","year":"2014","unstructured":"2. van Gerven NM, Verwer BJ, Witte BI, van Erpecum KJ, van Buuren HR, Maijers I, Visscher AP, Verschuren EC, van Hoek B, Coenraad MJ, Beuers UH, de Man RA, Drenth JP, den Ouden JW, Verdonk RC, Koek GH, Brouwer JT, Guichelaar MM, Vrolijk JM, Mulder CJ, van Nieuwkerk CM, Bouma G; Dutch Autoimmune hepatitis STUDY group. Epidemiology and clinical characteristics of autoimmune hepatitis in the Netherlands. Scand J Gastroenterol. 2014;49(10):1245-54.","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"key20231113133913_B3","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jhep.2013.10.020","article-title":"Autoimmune hepatitis in Denmark: incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study","volume":"60","author":"Gr\u00f8nb\u00e6k","year":"2014","unstructured":"3. Gr\u00f8nb\u00e6k L, Vilstrup H, Jepsen P. Autoimmune hepatitis in Denmark: incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study. J Hepatol. 2014;60(3):612-7.","journal-title":"J Hepatol"},{"issue":"4","key":"key20231113133913_B4","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jhep.2018.11.006","article-title":"Grand round: autoimmune hepatitis","volume":"70","author":"Trivedi","year":"2019","unstructured":"4. Trivedi PJ, Hubscher SG, Heneghan M, Gleeson D, Hirschfield GM. Grand round: autoimmune hepatitis. J Hepatol. 2019;70(4):773-84. Review.","journal-title":"J Hepatol"},{"issue":"2","key":"key20231113133913_B5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/cld.301","article-title":"Autoimmune hepatitis: histopathology","volume":"3","author":"Geller","year":"2014","unstructured":"5. Geller SA. Autoimmune hepatitis: histopathology. Clin Liver Dis (Hoboken). 2014;3(2):19-23. Review.","journal-title":"Clin Liver Dis"},{"issue":"3","key":"key20231113133913_B6","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/apt.12825","article-title":"Review article: chemokines as orchestrators of autoimmune hepatitis and potential therapeutic targets","volume":"40","author":"Czaja","year":"2014","unstructured":"6. Czaja AJ. Review article: chemokines as orchestrators of autoimmune hepatitis and potential therapeutic targets. Aliment Pharmacol Ther. 2014; 40(3):261-79. Review.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"key20231113133913_B7","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/flgastro-2018-101139","article-title":"Medical liver biopsy: background, indications, procedure and histopathology","volume":"11","author":"Boyd","year":"2020","unstructured":"7. Boyd A, Cain O, Chauhan A, Webb GJ. Medical liver biopsy: background, indications, procedure and histopathology. Frontline Gastroenterol. 2020;11(1):40-47. Review.","journal-title":"Frontline Gastroenterol"},{"issue":"4","key":"key20231113133913_B8","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s10620-006-3212-1","article-title":"Lupus-related hepatitis: complication of lupus or autoimmune association? Case report and review of the literature","volume":"51","author":"Kaw","year":"2006","unstructured":"8. Kaw R, Gota C, Bennett A, Barnes D, Calabrese L. Lupus-related hepatitis: complication of lupus or autoimmune association? Case report and review of the literature. Dig Dis Sci. 2006;51(4):813-8. Review.","journal-title":"Dig Dis Sci"},{"issue":"6","key":"key20231113133913_B9","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/liv.12155","article-title":"Anti-ribosomal P protein: a novel antibody in autoimmune hepatitis","volume":"33","author":"Calich","year":"2013","unstructured":"9. Calich AL, Viana VS, Cancado E, Tustumi F, Terrabuio DR, Leon EP, et al. Anti-ribosomal P protein: a novel antibody in autoimmune hepatitis. Liver Int. 2013;33(6): 909-13.","journal-title":"Liver Int"},{"issue":"1","key":"key20231113133913_B10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/08916930400022699","article-title":"Anti-ribosomal P protein antibodies","volume":"38","author":"Gerli","year":"2005","unstructured":"10. Gerli R, Caponi L. Anti-ribosomal P protein antibodies. Autoimmunity. 2005; 38(1):85-92. Review.","journal-title":"Autoimmunity"},{"issue":"1","key":"key20231113133913_B11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/liv.12333","article-title":"The antiribosomal P antibodies really elicit autoimmune hepatitis?","volume":"34","author":"Jearn","year":"2014","unstructured":"11. Jearn LH, Kim TY. The antiribosomal P antibodies really elicit autoimmune hepatitis? Liver Int. 2014;34(1):165-6.","journal-title":"Liver Int"},{"issue":"9","key":"key20231113133913_B12","doi-asserted-by":"crossref","DOI":"10.1111\/liv.12585","article-title":"Anti-ribosomal P protein antibody: an autoreactivity devoid of prognostic value in patients with autoimmune hepatitis","volume":"34","author":"Muratori","year":"2014","unstructured":"12. Muratori L, Masi C, Muratori P. Anti-ribosomal P protein antibody: an autoreactivity devoid of prognostic value in patients with autoimmune hepatitis. Liver Int. 2014;34(9):1446.","journal-title":"Liver Int"},{"issue":"6","key":"key20231113133913_B13","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","unstructured":"13. Manns MP, Czaja AJ, Gorham JD, Krawitt EL, Mieli-Vergani G, Vergani D, Vierling JM; American Association for the Study of Liver Diseases. Diagnosis and management of autoimmune hepatitis. Hepatology. 2010;51(6):2193-213.","journal-title":"Hepatology"},{"issue":"4","key":"key20231113133913_B14","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.4049\/jimmunol.135.4.2378","article-title":"Identification of ribosomal protein autoantigens","volume":"135","author":"Francoeur","year":"1985","unstructured":"14. Francoeur AM, Peebles CL, Heckman KJ, Lee JC, Tan EM. Identification of ribosomal protein autoantigens. J Immunol. 1985;135(4):2378-84.","journal-title":"J Immunol"},{"issue":"4","key":"key20231113133913_B15","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/jcla.20026","article-title":"Technical and clinical evaluation of anti-ribosomal P protein immunoassays","volume":"18","author":"Mahler","year":"2004","unstructured":"15. Mahler M, Kessenbrock K, Raats J, Fritzler MJ. Technical and clinical evaluation of anti-ribosomal P protein immunoassays. J Clin Lab Anal. 2004;18(4):215-23.","journal-title":"J Clin Lab Anal"},{"issue":"5","key":"key20231113133913_B16","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/apt.15111","article-title":"Review article: unanswered clinical and research questions in autoimmune hepatitis-conclusions of the International Autoimmune Hepatitis Group Research Workshop","volume":"49","author":"Dyson","year":"2019","unstructured":"16. Dyson JK, De Martin E, Dalekos GN, Drenth JP, Herkel J, Hubscher SG, Kelly D, Lenzi M, Milkiewicz P, Oo YH, Heneghan MA, Lohse AW; IAIHG Consortium. Review article: unanswered clinical and research questions in autoimmune hepatitis-conclusions of the International Autoimmune Hepatitis Group Research Workshop. Aliment Pharmacol Ther. 2019;49(5):528-36. Review.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"key20231113133913_B17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2014.05.004","article-title":"Emerging role of IL-17 and Th17 cells in systemic lupus erythematosus","volume":"154","author":"Martin","year":"2014","unstructured":"17. Martin JC, Baeten DL, Josien R. Emerging role of IL-17 and Th17 cells in systemic lupus erythematosus. Clin Immunol. 2014;154(1):1-12. Review.","journal-title":"Clin Immunol"},{"key":"key20231113133913_B18","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jaut.2013.07.004","article-title":"Novel insights into autoimmune liver diseases provided by genome-wide association studies","volume":"46","author":"Mells","year":"2013","unstructured":"18. Mells GF, Kaser A, Karlsen TH. Novel insights into autoimmune liver diseases provided by genome-wide association studies. J Autoimmun. 2013;46:41-54. Review.","journal-title":"J Autoimmun"},{"issue":"4","key":"key20231113133913_B19","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/gene.2014.82","article-title":"HLA-DRB1*03:01 and HLA-DRB1*04:01 modify the presentation and outcome in autoimmune hepatitis type-1","volume":"16","author":"van Gerven","year":"2015","unstructured":"19. van Gerven NM, de Boer YS, Zwiers A, Verwer BJ, Drenth JP, van Hoek B, van Erpecum KJ, Beuers U, van Buuren HR, den Ouden JW, Verdonk RC, Koek GH, Brouwer JT, Guichelaar MM, Vrolijk JM, Coenraad MJ, Kraal G, Mulder CJ, van Nieuwkerk CM, Bloemena E, Verspaget HW, Kumar V, Zhernakova A, Wijmenga C, Franke L, Bouma G; Dutch Autoimmune Hepatitis Study Group. HLA-DRB1*03:01 and HLA-DRB1*04:01 modify the presentation and outcome in autoimmune hepatitis type-1. Genes Immun. 2015;16(4):247-52.","journal-title":"Genes Immun"},{"key":"key20231113133913_B20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1006\/jaut.2002.0595","article-title":"Diagnostic tests for antiribosomal p protein antibodies: a comparative evaluation of immunoblotting and ELISA assays","volume":"19","author":"Ghirardello","year":"2002","unstructured":"20. Ghirardello A, Caponi L, Franceschini F, Zampieri S, Quinzanini M, Bendo R, et al. Diagnostic tests for antiribosomal p protein antibodies: a comparative evaluation of immunoblotting and ELISA assays. J Autoimmun. 2002; 19(1-2):71-7.","journal-title":"J Autoimmun"},{"issue":"1","key":"key20231113133913_B21","article-title":"Chemiluminescent immunoassay technology: what does it change in autoantibody detection?","volume":"8","author":"Cinquanta","year":"2017","unstructured":"21. Cinquanta L, Fontana DE, Bizzaro N. Chemiluminescent immunoassay technology: what does it change in autoantibody detection? Auto Immun Highlights. 2017;8(1):9.","journal-title":"Auto Immun Highlights"}],"container-title":["einstein (S\u00e3o Paulo)"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T18:39:27Z","timestamp":1699900767000},"score":1,"resource":{"primary":{"URL":"https:\/\/journal.einstein.br\/article\/anti-ribosomal-p-anti-p-antibodies-in-patients-with-autoimmune-hepatitis\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":21,"alternative-id":["10.31744\/einstein_journal\/2023AO0375"],"URL":"https:\/\/doi.org\/10.31744\/einstein_journal\/2023ao0375","relation":{},"ISSN":["1679-4508","2317-6385"],"issn-type":[{"value":"1679-4508","type":"print"},{"value":"2317-6385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"article-number":"eAO0375"}}